DK1992697T3 - Fremstilling af TNFR-Fc - Google Patents

Fremstilling af TNFR-Fc

Info

Publication number: DK1992697T3
Authority: DK; Denmark
Prior art keywords: tnfr; preparation
Prior art date: 2004-08-27

Application number

DK08005732.6T

Other languages

English (en)

Inventor

Denis Drapeau

James R Mercer

Wenge Wang

Yen-Tung Luan

Daniel R Lasko

Original Assignee

Wyeth Res Ireland Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-08-27

Filing date

2005-08-26

Publication date

2010-05-17

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35500648&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1992697(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-08-26 Application filed by Wyeth Res Ireland Ltd filed Critical Wyeth Res Ireland Ltd

2010-05-17 Application granted granted Critical

2010-05-17 Publication of DK1992697T3 publication Critical patent/DK1992697T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
- C12N2500/95—Protein-free medium and culture conditions

Landscapes

Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
Biotechnology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
Microbiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Biophysics (AREA)
Medicinal Chemistry (AREA)
Toxicology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Cell Biology (AREA)
Biomedical Technology (AREA)
Physics & Mathematics (AREA)
Plant Pathology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

DK08005732.6T 2004-08-27 2005-08-26 Fremstilling af TNFR-Fc DK1992697T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US60537904P	2004-08-27	2004-08-27
EP05791482A EP1781802B1 (en)	2004-08-27	2005-08-26	Production of a tnfr-ig fusion protein

Publications (1)

Publication Number	Publication Date
DK1992697T3 true DK1992697T3 (da)	2010-05-17

Family

ID=35500648

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK05791482.2T DK1781802T3 (da)	2004-08-27	2005-08-26	Fremstilling af et TNFR-Ig-fusionsprotein
DK08005732.6T DK1992697T3 (da)	2004-08-27	2005-08-26	Fremstilling af TNFR-Fc

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DK05791482.2T DK1781802T3 (da)	2004-08-27	2005-08-26	Fremstilling af et TNFR-Ig-fusionsprotein

Country Status (37)

Country	Link
US (1)	US7300773B2 (da)
EP (2)	EP1992697B1 (da)
JP (3)	JP2008511330A (da)
KR (1)	KR100988451B1 (da)
CN (2)	CN101061231B (da)
AR (2)	AR050537A1 (da)
AT (2)	ATE461285T1 (da)
AU (1)	AU2005280036B2 (da)
BR (1)	BRPI0514694B8 (da)
CA (1)	CA2578138C (da)
CL (1)	CL2017000577A1 (da)
CR (2)	CR8998A (da)
CY (2)	CY1109721T1 (da)
DE (2)	DE602005017285D1 (da)
DK (2)	DK1781802T3 (da)
EC (1)	ECSP077354A (da)
EG (1)	EG26922A (da)
ES (2)	ES2335518T3 (da)
GT (2)	GT200500233A (da)
HN (1)	HN2005000485A (da)
HR (2)	HRP20100011T1 (da)
IL (1)	IL181588A (da)
MX (1)	MX2007002381A (da)
MY (1)	MY137803A (da)
NO (1)	NO344785B1 (da)
NZ (1)	NZ579208A (da)
PE (2)	PE20100448A1 (da)
PL (2)	PL1992697T3 (da)
PT (2)	PT1781802E (da)
RS (2)	RS51255B (da)
RU (1)	RU2458988C2 (da)
SI (2)	SI1992697T1 (da)
SV (1)	SV2006002211A (da)
TW (1)	TWI364458B (da)
UA (1)	UA89383C2 (da)
WO (1)	WO2006026447A2 (da)
ZA (1)	ZA200701672B (da)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI374935B (en)	2004-08-27	2012-10-21	Pfizer Ireland Pharmaceuticals	Production of α-abeta
US7294484B2 (en) *	2004-08-27	2007-11-13	Wyeth Research Ireland Limited	Production of polypeptides
EP1909831A4 (en)	2005-06-14	2013-02-20	Amgen Inc	SELF-BUFFING PROTEIN FORMULATIONS
PE20070796A1 (es) *	2005-10-24	2007-08-15	Wyeth Corp	Metodo de produccion proteica utilizando compuestos anti-senescencia
US20070231895A1 (en) *	2005-11-02	2007-10-04	Lee Gene W	Methods for adapting mammalian cells
DK2041270T3 (da) *	2006-07-13	2014-01-27	Wyeth Llc	Fremstilling af glycoproteiner
CA2666317C (en) *	2006-11-03	2013-08-06	Wyeth	Glycolysis-inhibiting substances in cell culture
KR101523782B1 (ko) *	2006-11-08	2015-05-28	와이어쓰 엘엘씨	세포 배양을 위한 합리적으로 설계된 배지
KR20090127326A (ko) *	2007-03-02	2009-12-10	와이어쓰	폴리펩티드의 생산을 위한 세포 배양물 중에서 구리 및 글루타메이트의 용도
TW200902708A (en) *	2007-04-23	2009-01-16	Wyeth Corp	Methods of protein production using anti-senescence compounds
TWI601823B (zh)	2007-04-26	2017-10-11	Chugai Pharmaceutical Co Ltd	Cell culture methods using media containing high concentrations of amino acids
DK2310523T3 (da) *	2008-04-17	2015-07-20	Wyeth Llc	Fremgangsmåder til forøget produktion af knoglemorfogenetiske proteiner
JP2011516086A (ja) *	2008-04-18	2011-05-26	上海中信国健薬業股▲ふん▼有限公司	濃縮培養液及びその使用方法
EP2331700A2 (en)	2008-08-08	2011-06-15	Biogen Idec MA Inc.	Nutrient monitoring and feedback control for increased bioproduct production
SI2464725T2 (sl)	2009-08-11	2025-06-30	F. Hoffmann-La Roche Ag	Proizvodnja beljakovin v medijih za celične kulture brez glutamina
RU2012127383A (ru) *	2009-12-02	2014-01-10	Акселерон Фарма Инк.	Композиции и способы для увеличения времени полужизни fc-слитых белков в сыворотке
EP3862423A1 (en)	2010-04-26	2021-08-11	Novartis AG	Improved cell cultivation process
US8986957B2 (en)	2010-04-26	2015-03-24	Novartis Ag	Cell culture medium
JP2013535981A (ja)	2010-08-20	2013-09-19	ワイス・エルエルシー	成長因子不含適合細胞の細胞培養
WO2012068134A1 (en)	2010-11-15	2012-05-24	Biogen Idec Inc.	Enrichment and concentration of select product isoforms by overloaded bind and elute chromatography
EP2702164B8 (en)	2011-04-29	2016-03-16	Biocon Research Limited	A method for reducing heterogeneity of antibodies and a process of producing the antibodies thereof
EP2718328A4 (en)	2011-06-08	2014-12-24	Acceleron Pharma Inc	COMPOSITIONS AND METHODS FOR INCREASING THE HALF TIME OF SERUM
US10485869B2 (en)	2011-10-18	2019-11-26	Coherus Biosciences, Inc.	Etanercept formulations stabilized with meglumine
BR112014009031A2 (pt)	2011-10-18	2017-05-09	Coherus Biosciences Inc	formulações de etanercept estabilizadas com íons de metais
KR20170021919A (ko) *	2011-10-21	2017-02-28	화이자 인코포레이티드	철을 첨가하여 세포 배양을 개선하는 방법
CN104159916A (zh) *	2012-02-22	2014-11-19	Nvip私人有限公司	肿瘤坏死因子受体融合蛋白及其使用方法
MX2015000337A (es)	2012-07-09	2015-09-25	Coherus Biosciences Inc	Formulaciones de etanercept que exhiben reduccion notable en particulas subvisibles.
LT2895188T (lt)	2012-09-11	2018-04-10	Coherus Biosciences, Inc.	Aukšto grynumo ir geros išeigos teisingos struktūros etanerceptas
US9217168B2 (en)	2013-03-14	2015-12-22	Momenta Pharmaceuticals, Inc.	Methods of cell culture
SG11201507875RA (en)	2013-03-26	2015-10-29	Coherus Biosciences Inc	Protein production method
KR101439195B1 (ko)	2013-04-18	2014-09-12	동아대학교 산학협력단	에셰리키아 콜리 a-53 균주를 이용하여 섬유소 분해효소의 생산성을 향상시키는 공정
ES2833471T3 (es) *	2013-10-11	2021-06-15	Regeneron Pharma	Cultivo celular metabólicamente optimizado
US11390663B2 (en)	2013-10-11	2022-07-19	Regeneron Pharmaceuticals, Inc.	Metabolically optimized cell culture
US10047141B2 (en)	2014-01-30	2018-08-14	Coherus Biosciences, Inc.	Method of manufacturing a protein by perfusion in media with a low amino acid concentration
KR102382402B1 (ko)	2014-02-04	2022-04-01	바이오젠 엠에이 인코포레이티드	번역 후 변형을 강화시키기 위한 통류 방식 양이온 교환 크로마토그래피의 용도
EP3227454B1 (en) *	2014-12-01	2020-01-29	Amgen Inc.	Process for manipulating the level of glycan content of a glycoprotein
KR102007930B1 (ko)	2014-12-31	2019-08-06	주식회사 엘지화학	재조합 당단백질의 글리코실화 조절 방법
CN105777897A (zh) *	2015-03-20	2016-07-20	广东东阳光药业有限公司	一种cho细胞收获液的前处理方法
SG11201705743YA (en) *	2015-04-01	2017-08-30	Boehringer Ingelheim Int	Cell culture medium
KR101936049B1 (ko) *	2015-10-15	2019-01-08	(주)알테오젠	IgG Fc 도메인을 가지는 융합 단백질의 생산방법
AU2017345490B2 (en)	2016-10-21	2022-07-07	Amgen Inc.	Pharmaceutical formulations and methods of making the same
GB201708655D0 (en)	2017-05-31	2017-07-12	Ucb Biopharma Sprl	Cell culture methods
CN110484487A (zh) *	2019-08-21	2019-11-22	安徽欣乐生物技术有限公司	一种适用于cho细胞培养用无蛋白培养基及其培养方法
EP4267717A1 (en)	2020-12-22	2023-11-01	Amgen Inc.	Cell culture method
CN115073607A (zh) *	2021-03-12	2022-09-20	上海康岱生物医药技术股份有限公司	Tnfr2与baff受体的融合蛋白
CN114480492B (zh) *	2022-01-28	2023-04-21	景泽生物医药(合肥)股份有限公司	一种重组人抗体融合蛋白的制备方法
CN119510778A (zh) *	2024-12-31	2025-02-25	北京同立海源生物科技有限公司	一种高稳定性的pdgf-bb活性检测方法

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4399216A (en) *	1980-02-25	1983-08-16	The Trustees Of Columbia University	Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
US4522811A (en) *	1982-07-08	1985-06-11	Syntex (U.S.A.) Inc.	Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
AU2353384A (en)	1983-01-19	1984-07-26	Genentech Inc.	Amplification in eukaryotic host cells
US4713339A (en)	1983-01-19	1987-12-15	Genentech, Inc.	Polycistronic expression vector construction
GB8308235D0 (en) *	1983-03-25	1983-05-05	Celltech Ltd	Polypeptides
US4816567A (en) *	1983-04-08	1989-03-28	Genentech, Inc.	Recombinant immunoglobin preparations
JPS6147500A (ja)	1984-08-15	1986-03-07	Res Dev Corp Of Japan	キメラモノクロ−ナル抗体及びその製造法
EP0173494A3 (en)	1984-08-27	1987-11-25	The Board Of Trustees Of The Leland Stanford Junior University	Chimeric receptors by dna splicing and expression
GB8422238D0 (en)	1984-09-03	1984-10-10	Neuberger M S	Chimeric proteins
US5672502A (en) *	1985-06-28	1997-09-30	Celltech Therapeutics Limited	Animal cell culture
GB8607679D0 (en)	1986-03-27	1986-04-30	Winter G P	Recombinant dna product
US6048728A (en) *	1988-09-23	2000-04-11	Chiron Corporation	Cell culture medium for enhanced cell growth, culture longevity, and product expression
EP0435911B1 (en) *	1988-09-23	1996-03-13	Cetus Oncology Corporation	Cell culture medium for enhanced cell growth, culture longevity and product expression
US6291159B1 (en) *	1989-05-16	2001-09-18	Scripps Research Institute	Method for producing polymers having a preselected activity
NZ235148A (en) *	1989-09-05	1991-12-23	Immunex Corp	Tumour necrosis factor receptor protein and dna sequences
US5605690A (en) *	1989-09-05	1997-02-25	Immunex Corporation	Methods of lowering active TNF-α levels in mammals using tumor necrosis factor receptor
US5395760A (en) *	1989-09-05	1995-03-07	Immunex Corporation	DNA encoding tumor necrosis factor-α and -β receptors
JPH0396383A (ja)	1989-09-08	1991-04-22	Riso Kagaku Corp	画像形成装置
DE10399023I2 (de)	1989-09-12	2006-11-23	Ahp Mfg B V	TFN-bindende Proteine
CA2067194C (en) *	1989-10-05	2003-03-18	Glenn Kawasaki	Cell-free synthesis and isolation of novel genes and polypeptides
US6657103B1 (en) *	1990-01-12	2003-12-02	Abgenix, Inc.	Human antibodies derived from immunized xenomice
US5538983A (en) *	1990-05-16	1996-07-23	The Rockefeller University	Method of treating amyloidosis by modulation of calcium
US5156964A (en) *	1990-08-16	1992-10-20	Cetus Corporation	Methods for adapting cells for increased product production through exposure to ammonia
US5122469A (en) *	1990-10-03	1992-06-16	Genentech, Inc.	Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
GB9021679D0 (en)	1990-10-05	1990-11-21	Gorman Scott David	Antibody preparation
GB9022545D0 (en)	1990-10-17	1990-11-28	Wellcome Found	Culture medium
GB2251249B (en)	1990-12-28	1995-06-21	Mogam Biotech Res Inst	High-density medium for animal cell culture
GB9118664D0 (en) *	1991-08-30	1991-10-16	Celltech Ltd	Cell culture
US5447851B1 (en) *	1992-04-02	1999-07-06	Univ Texas System Board Of	Dna encoding a chimeric polypeptide comprising the extracellular domain of tnf receptor fused to igg vectors and host cells
JP3504963B2 (ja)	1993-10-22	2004-03-08	智靖羅	抗ヒト高親和性ＩｇＥ受容体モノクローナル抗体に係るアミノ酸配列をコードするＤＮＡ断片
US6310185B1 (en) *	1994-03-08	2001-10-30	Memorial Sloan Kettering Cancer Center	Recombinant human anti-Lewis Y antibodies
US5856179A (en) *	1994-03-10	1999-01-05	Genentech, Inc.	Polypeptide production in animal cell culture
US5589154A (en) *	1994-11-22	1996-12-31	Rutgers, The State University Of New Jersey	Methods for the prevention or treatment of vascular hemorrhaging and Alzheimer's disease
IL117175A (en) *	1995-02-20	2005-11-20	Sankyo Co	Osteoclastogenesis inhibitory factor protein
US6656466B1 (en) *	1995-06-06	2003-12-02	Genetech, Inc.	Human tumor necrosis factor—immunoglobulin(TNFR1-IgG1) chimera composition
US5721121A (en) *	1995-06-06	1998-02-24	Genentech, Inc.	Mammalian cell culture process for producing a tumor necrosis factor receptor immunoglobulin chimeric protein
US5705364A (en)	1995-06-06	1998-01-06	Genentech, Inc.	Mammalian cell culture process
JP4306813B2 (ja) *	1995-09-19	2009-08-05	アスビオファーマ株式会社	動物細胞の新規培養方法
US20020012991A1 (en)	1997-04-07	2002-01-31	Florence Chua Nee Ho Kit Fong	Cell culture media for enhanced protein production
US7964192B1 (en)	1997-12-02	2011-06-21	Janssen Alzheimer Immunotherapy	Prevention and treatment of amyloidgenic disease
CA2354862A1 (en)	1998-10-19	2000-04-27	Yeda Research And Development Co. Ltd.	Treatment of systemic lupus erythematosus by down-regulating the autoimmune response to autoantigens
PE20020574A1 (es)	2000-12-06	2002-07-02	Wyeth Corp	Anticuerpos humanizados que reconocen el peptido amiloideo beta
TW200526779A (en)	2001-02-08	2005-08-16	Wyeth Corp	Modified and stabilized GDF propeptides and uses thereof
ES2312569T3 (es)	2001-04-30	2009-03-01	Eli Lilly And Company	Anticuerpos humanizados.
ATE420114T1 (de)	2001-04-30	2009-01-15	Lilly Co Eli	Humanisierte antikörper die das beta-amyloid peptid erkennen& x9;
CA2447791A1 (en)	2001-06-13	2002-12-19	Neslihan Delacruz	Methods of culturing animal cells and polypeptide production in animal cells
US7320789B2 (en)	2001-09-26	2008-01-22	Wyeth	Antibody inhibitors of GDF-8 and uses thereof
MXPA04008149A (es)	2002-02-21	2005-06-17	Wyeth Corp	Proteinas que contienen dominios de folistatina.
MXPA04008150A (es)	2002-02-21	2005-06-17	Wyeth Corp	Gasp1: una proteina que contiene dominio de folistatina.
MY139983A (en)	2002-03-12	2009-11-30	Janssen Alzheimer Immunotherap	Humanized antibodies that recognize beta amyloid peptide
TWI438010B (zh)	2002-05-02	2014-05-21	Wyeth Corp	卡奇黴素（ｃａｌｉｃｈｅａｍｉｃｉｎ）衍生物-載體共軛物
US7261893B2 (en)	2002-10-22	2007-08-28	Wyeth	Neutralizing antibodies against GDF-8 and uses therefor
US20040223966A1 (en)	2002-10-25	2004-11-11	Wolfman Neil M.	ActRIIB fusion polypeptides and uses therefor
TWI374935B (en)	2004-08-27	2012-10-21	Pfizer Ireland Pharmaceuticals	Production of α-abeta
US7294484B2 (en)	2004-08-27	2007-11-13	Wyeth Research Ireland Limited	Production of polypeptides

2005
- 2005-08-25 US US11/213,633 patent/US7300773B2/en not_active Expired - Lifetime
- 2005-08-25 TW TW094129077A patent/TWI364458B/zh not_active IP Right Cessation
- 2005-08-26 GT GT200500233A patent/GT200500233A/es unknown
- 2005-08-26 PE PE2009001227A patent/PE20100448A1/es active IP Right Grant
- 2005-08-26 AT AT08005732T patent/ATE461285T1/de active
- 2005-08-26 DK DK05791482.2T patent/DK1781802T3/da active
- 2005-08-26 PT PT05791482T patent/PT1781802E/pt unknown
- 2005-08-26 EP EP08005732A patent/EP1992697B1/en not_active Revoked
- 2005-08-26 DK DK08005732.6T patent/DK1992697T3/da active
- 2005-08-26 AU AU2005280036A patent/AU2005280036B2/en not_active Expired
- 2005-08-26 MX MX2007002381A patent/MX2007002381A/es active IP Right Grant
- 2005-08-26 RS RSP-2010/0190A patent/RS51255B/sr unknown
- 2005-08-26 ES ES05791482T patent/ES2335518T3/es not_active Expired - Lifetime
- 2005-08-26 CN CN2005800369388A patent/CN101061231B/zh not_active Expired - Fee Related
- 2005-08-26 PL PL08005732T patent/PL1992697T3/pl unknown
- 2005-08-26 CA CA2578138A patent/CA2578138C/en not_active Expired - Lifetime
- 2005-08-26 SI SI200530984T patent/SI1992697T1/sl unknown
- 2005-08-26 HR HR20100011T patent/HRP20100011T1/hr unknown
- 2005-08-26 ES ES08005732T patent/ES2341390T3/es not_active Expired - Lifetime
- 2005-08-26 HN HN2005000485A patent/HN2005000485A/es unknown
- 2005-08-26 SV SV2005002211A patent/SV2006002211A/es unknown
- 2005-08-26 RU RU2007108717/10A patent/RU2458988C2/ru active
- 2005-08-26 NZ NZ579208A patent/NZ579208A/en not_active IP Right Cessation
- 2005-08-26 UA UAA200703287A patent/UA89383C2/ru unknown
- 2005-08-26 KR KR1020077004810A patent/KR100988451B1/ko not_active Expired - Lifetime
- 2005-08-26 GT GT200500234A patent/GT200500234A/es unknown
- 2005-08-26 DE DE602005017285T patent/DE602005017285D1/de not_active Expired - Lifetime
- 2005-08-26 WO PCT/US2005/030439 patent/WO2006026447A2/en not_active Ceased
- 2005-08-26 AT AT05791482T patent/ATE446376T1/de active
- 2005-08-26 PE PE2005000987A patent/PE20060815A1/es not_active Application Discontinuation
- 2005-08-26 JP JP2007530167A patent/JP2008511330A/ja active Pending
- 2005-08-26 EP EP05791482A patent/EP1781802B1/en not_active Revoked
- 2005-08-26 RS RSP-2009/0575A patent/RS51072B/sr unknown
- 2005-08-26 DE DE602005020076T patent/DE602005020076D1/de not_active Expired - Lifetime
- 2005-08-26 PL PL05791482T patent/PL1781802T3/pl unknown
- 2005-08-26 SI SI200530874T patent/SI1781802T1/sl unknown
- 2005-08-26 AR ARP050103596A patent/AR050537A1/es not_active Application Discontinuation
- 2005-08-26 CN CN2012102771283A patent/CN102876761A/zh active Pending
- 2005-08-26 BR BRPI0514694A patent/BRPI0514694B8/pt active IP Right Grant
- 2005-08-26 PT PT08005732T patent/PT1992697E/pt unknown
- 2005-08-26 MY MYPI20054023A patent/MY137803A/en unknown
2007
- 2007-02-26 ZA ZA2007/01672A patent/ZA200701672B/en unknown
- 2007-02-27 IL IL181588A patent/IL181588A/en unknown
- 2007-02-27 EG EGNA2007000222 patent/EG26922A/xx active
- 2007-03-16 CR CR8998A patent/CR8998A/es unknown
- 2007-03-26 NO NO20071570A patent/NO344785B1/no not_active IP Right Cessation
- 2007-03-27 EC EC2007007354A patent/ECSP077354A/es unknown
2010
- 2010-01-08 CY CY20101100022T patent/CY1109721T1/el unknown
- 2010-05-14 HR HR20100271T patent/HRP20100271T1/hr unknown
- 2010-06-16 CY CY20101100556T patent/CY1110092T1/el unknown
2012
- 2012-02-17 JP JP2012033112A patent/JP5921910B2/ja not_active Expired - Lifetime
- 2012-11-01 CR CR20120560A patent/CR20120560A/es unknown
- 2012-11-09 AR ARP120104234A patent/AR088824A2/es not_active Application Discontinuation
2016
- 2016-01-28 JP JP2016014650A patent/JP2016056214A/ja active Pending
2017
- 2017-03-09 CL CL2017000577A patent/CL2017000577A1/es unknown

Also Published As

Publication number	Publication date
PT1992697E (pt)	2010-04-21
JP2008511330A (ja)	2008-04-17
EP1992697B1 (en)	2010-03-17
DK1781802T3 (da)	2010-01-25
ES2335518T3 (es)	2010-03-29
BRPI0514694A (pt)	2008-06-17
SI1781802T1 (sl)	2010-01-29
ZA200701672B (en)	2012-04-24
JP2016056214A (ja)	2016-04-21
AR050537A1 (es)	2006-11-01
JP5921910B2 (ja)	2016-05-24
MX2007002381A (es)	2007-06-15
CY1109721T1 (el)	2014-08-13
KR100988451B1 (ko)	2010-10-18
MY137803A (en)	2009-03-31
CL2017000577A1 (es)	2017-12-01
AU2005280036A1 (en)	2006-03-09
BRPI0514694B8 (pt)	2021-05-25
PT1781802E (pt)	2010-01-04
RS51255B (sr)	2010-12-31
DE602005020076D1 (de)	2010-04-29
EP1781802B1 (en)	2009-10-21
WO2006026447A2 (en)	2006-03-09
NO344785B1 (no)	2020-04-27
IL181588A (en)	2010-12-30
CR20120560A (es)	2012-12-04
HN2005000485A (es)	2009-06-09
US7300773B2 (en)	2007-11-27
PE20100448A1 (es)	2010-06-22
WO2006026447A3 (en)	2006-04-20
EP1992697A1 (en)	2008-11-19
CN102876761A (zh)	2013-01-16
AR088824A2 (es)	2014-07-10
CA2578138A1 (en)	2006-03-09
HRP20100271T1 (hr)	2010-06-30
GT200500233A (es)	2006-03-09
CR8998A (es)	2007-11-23
GT200500234A (es)	2006-10-10
DE602005017285D1 (da)	2009-12-03
HK1121497A1 (en)	2009-04-24
HK1099941A1 (en)	2007-08-31
CA2578138C (en)	2010-10-05
ATE461285T1 (de)	2010-04-15
TW200619388A (en)	2006-06-16
TWI364458B (en)	2012-05-21
KR20070069140A (ko)	2007-07-02
SI1992697T1 (sl)	2010-07-30
PL1781802T3 (pl)	2010-03-31
IL181588A0 (en)	2007-07-04
ES2341390T3 (es)	2010-06-18
EG26922A (en)	2014-12-25
NO20071570L (no)	2007-05-23
US20060121569A1 (en)	2006-06-08
PL1992697T3 (pl)	2010-08-31
UA89383C2 (ru)	2010-01-25
BRPI0514694B1 (pt)	2019-04-24
RU2007108717A (ru)	2008-10-10
SV2006002211A (es)	2006-10-04
HRP20100011T1 (hr)	2010-02-28
ATE446376T1 (de)	2009-11-15
ECSP077354A (es)	2007-05-30
RU2458988C2 (ru)	2012-08-20
RS51072B (sr)	2010-10-31
WO2006026447A9 (en)	2006-06-01
NZ579208A (en)	2012-01-12
CN101061231B (zh)	2012-09-26
AU2005280036B2 (en)	2011-11-03
EP1781802A2 (en)	2007-05-09
CN101061231A (zh)	2007-10-24
PE20060815A1 (es)	2006-09-14
JP2012095672A (ja)	2012-05-24
CY1110092T1 (el)	2015-01-14

Publication	Publication Date	Title
DK1992697T3 (da)	2010-05-17	Fremstilling af TNFR-Fc
DK1802579T3 (da)	2014-01-20	Derivater af 3-arylaminopyridin
DK2363414T3 (da)	2022-08-08	Stedstyret modifikation af FVIII
DK1778618T3 (da)	2014-03-10	Syntese af triethylentetraminer
DK1877568T3 (da)	2012-12-03	Hydrolysering af arabinoxylan
DK1828164T3 (da)	2008-12-08	Fremgangsmåde til fremstilling af N-phenylpyrazol-1-carboxamider
DK1778668T3 (da)	2013-09-30	Fremgangsmåde til fremstilling af dihydropteridion
DK1720866T3 (da)	2011-11-21	Fremgangsmåde
DK1831154T3 (da)	2010-04-12	Fremstilling af pregabalin og relaterede forbindelser
DK1636190T3 (da)	2012-09-24	Stabilt krystal af 4-oxoquinolinforbindelse
DK1745062T3 (da)	2014-08-11	Forbedrede modulatorer af koagulationsfaktorer
DK1791820T3 (da)	2010-04-06	Enantioselektiv fremstilling af quinolinderivater
DK1937071T3 (da)	2011-11-28	Krystallinske modifikationer af pyraclostrobin
DK1587542T3 (da)	2012-07-30	Anvendelse af anti-CD100-antistoffer
DK1931315T3 (da)	2014-01-20	Depotformuleringer af nalbufin
DK1917267T3 (da)	2009-04-14	Krystalform af asenapinmaleat
DK1940465T3 (da)	2012-10-22	Ny anvendelse af anti-IL-1beta-antistoffer
DK1879844T3 (da)	2011-07-25	Fremstilling af natriumdiformiat
NO20043305D0 (no)	2004-08-09	Preparation of lodixanol
DK1827483T3 (da)	2014-10-06	Terapeutiske formuleringer af keratinocyt-vækstfaktor
DK1773787T3 (da)	2014-06-23	Fremgangsmåde til fremstilling af 3-phenyl(thio)uraciler og -dithiouraciler
DK1763520T3 (da)	2009-02-09	Anvendelse af trisubstituerede benzopyranoner
DK1831223T3 (da)	2013-06-10	Fremgangsmåde til fremstilling af L-biopterin
DK1631261T3 (da)	2009-11-09	Fremstilling af små partikler
DK1794111T3 (da)	2014-10-13	Fremgangsmåde til fremstilling af cyclopentanon